Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Listed Suppliers
Reliable Spanish CDMO Delivering High-Quality APIs and Intermediates with Excellence, Flexibility, and Regulatory Compliance.
About the Company : Kinsy, an independent CDMO in Spain, offers over 30 years of expertise in developing and manufacturing advanced pharmaceutical intermediates and APIs. We provide innovative route d...
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
89
PharmaCompass offers a list of L-Fucose API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L-Fucose manufacturer or L-Fucose supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L-Fucose manufacturer or L-Fucose supplier.
PharmaCompass also assists you with knowing the L-Fucose API Price utilized in the formulation of products. L-Fucose API Price is not always fixed or binding as the L-Fucose Price is obtained through a variety of data sources. The L-Fucose Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L-Fucose manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L-Fucose, including repackagers and relabelers. The FDA regulates L-Fucose manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L-Fucose API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L-Fucose manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L-Fucose supplier is an individual or a company that provides L-Fucose active pharmaceutical ingredient (API) or L-Fucose finished formulations upon request. The L-Fucose suppliers may include L-Fucose API manufacturers, exporters, distributors and traders.
click here to find a list of L-Fucose suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L-Fucose Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L-Fucose GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L-Fucose GMP manufacturer or L-Fucose GMP API supplier for your needs.
A L-Fucose CoA (Certificate of Analysis) is a formal document that attests to L-Fucose's compliance with L-Fucose specifications and serves as a tool for batch-level quality control.
L-Fucose CoA mostly includes findings from lab analyses of a specific batch. For each L-Fucose CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L-Fucose may be tested according to a variety of international standards, such as European Pharmacopoeia (L-Fucose EP), L-Fucose JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L-Fucose USP).
